HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differences in Symptomatic Presentation and Cognitive Performance Among Participants With LATE-NC Compared to FTLD-TDP.

Abstract
Transactive response DNA-binding protein 43 kDa (TDP-43) is aberrantly aggregated and phosphorylated in frontotemporal lobar degeneration of the TDP-43 type (FTLD-TDP), and in limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC). We examined data from the National Alzheimer's Coordinating Center to compare clinical features of autopsy-confirmed LATE-NC and FTLD-TDP. A total of 265 LATE-NC and 92 FTLD-TDP participants were included. Cognitive and behavioral symptoms were compared, stratified by level of impairment based on global clinical dementia rating (CDR) score. LATE-NC participants were older at death, more likely to carry APOE ε4, more likely to have Alzheimer disease neuropathology, and had lower (i.e. less severe) final CDR global scores than those with FTLD-TDP. Participants with FTLD-TDP were more likely to present with primary progressive aphasia, or behavior problems such as apathy, disinhibition, and personality changes. Among participants with final CDR score of 2-3, those with LATE-NC were more likely to have visuospatial impairment, delusions, and/or visual hallucinations. These differences were robust after sensitivity analyses excluding older (≥80 years at death), LATE-NC stage 3, or severe Alzheimer cases. Overall, FTLD-TDP was more globally severe, and affected younger participants, whereas psychoses were more common in LATE-NC.
AuthorsMerilee A Teylan, Charles Mock, Kathryn Gauthreaux, Jessica E Culhane, Gregory Jicha, Yen-Chi Chen, Kwun C G Chan, Walter A Kukull, Peter T Nelson, Yuriko Katsumata
JournalJournal of neuropathology and experimental neurology (J Neuropathol Exp Neurol) Vol. 80 Issue 11 Pg. 1024–1032 (11 19 2021) ISSN: 1554-6578 [Electronic] England
PMID34597386 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 American Association of Neuropathologists, Inc. All rights reserved.
Chemical References
  • Apolipoprotein E4
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (pathology)
  • Aphasia, Primary Progressive (complications, pathology)
  • Apolipoprotein E4 (genetics)
  • Cognition
  • Delusions (etiology, psychology)
  • Female
  • Frontotemporal Lobar Degeneration (diagnosis, genetics, psychology)
  • Hallucinations (etiology, psychology)
  • Heterozygote
  • Humans
  • Limbic System (pathology)
  • Male
  • Middle Aged
  • Neurofibrillary Tangles (pathology)
  • Neuropsychological Tests
  • Psychomotor Performance
  • TDP-43 Proteinopathies (diagnosis, genetics, psychology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: